This one is more for the cardiologists among you, however it is a technique that is becoming increasingly common. Transcatheter aortic valve replacement or implantation is generally indicated for the treatment of severe symptomatic aortic stenosis in patients with inoperable or high risk but operable comorbidities. Here, the results from all US TAVR cases (almost eight thousand cases) are presented.
So, what do you need to know?
- average age was 84
- About half are women
- the STS predicted mortality was 7% – actual in hospital mortality was 5.5%, and 7.6% at 30 days
- 64% were done from the femoral approach
- there was a 2% stroke rate
- 1.9% required dialysis due to renal failure
- 0.5% of patients required intervention
An interesting read regarding TAVR/TAVI in general, and useful to provide more information to patients. Check it out here.
source | Journal of the American Medical Association
image | Heart Hospital of Austin
medjuice 